[
  {
    "date": "2023-12-30",
    "symbol": "VRPX",
    "period": "FY",
    "cash": 9141512,
    "prepaidexpenseandotherassetscurrent": 486833,
    "assetscurrent": 9628345,
    "assets": 9628345,
    "accountspayableandaccruedliabilitiescurrent": 1694024,
    "litigationreservecurrent": 6000000,
    "liabilitiescurrent": 7694024,
    "liabilities": 7694024,
    "commonstockvalue": 12,
    "additionalpaidincapital": 61478444,
    "retainedearningsaccumulateddeficit": -59544135,
    "stockholdersequity": 1934321,
    "liabilitiesandstockholdersequity": 9628345,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 1171233,
    "commonstocksharesoutstanding": 1171233,
    "generalandadministrativeexpense": 10572181,
    "researchanddevelopmentexpense": 5117608,
    "operatingexpenses": 15689789,
    "operatingincomeloss": -15689789,
    "nonoperatingincomeexpense": 500281,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -15189508,
    "netincomeloss": -15189508,
    "earningspersharebasic": -12.97,
    "weightedaveragenumberofsharesoutstandingbasic": 1171233,
    "insurancerecoveries": 1250000,
    "earningspersharediluted": -12.97,
    "weightedaveragenumberofdilutedsharesoutstanding": 1171233,
    "sharesoutstanding": 1171233,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 544770,
    "sharebasedcompensation": 544770,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -191532,
    "increasedecreaseinaccountspayableandaccruedliabilities": 599434,
    "increasedecreaseinestimatedlitigationliability": 4000000,
    "netcashprovidedbyusedinoperatingactivities": -9853772,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -9853772,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 9141512,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 175686,
    "prepaidinsurance": 136241,
    "prepaidresearchanddevelopment": 283370,
    "otherprepaidexpensecurrent": 67222,
    "accruedpayrolltaxescurrent": 493780,
    "estimatedseparationexpense": 711000,
    "accruedresearchanddevelopmentexpenses": 143071,
    "accruedlegalexpenses": 97089,
    "accruedprofessionalfeescurrent": 230627,
    "otheraccruedliabilitiescurrent": 18457,
    "allocatedsharebasedcompensationexpense": 335363,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0367,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.1312,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 98886,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 55.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P9Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 82880,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 61.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 24050,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisepricecancelledweightedaverageexerciseprice": 8.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 100850,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.8,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y1M6D",
    "deferredtaxassetsoperatinglosscarryforwards": 8854000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 3562000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 829000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1989000,
    "deferredtaxassetsinprocessresearchanddevelopment": 654000,
    "deferredtaxassetsother": 5000,
    "deferredtaxassetsgross": 15893000,
    "deferredtaxassetsvaluationallowance": 15893000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.05,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.092,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.171,
    "effectiveincometaxratereconciliationotheradjustments": 0.003,
    "cashfdicinsuredamount": 8900000,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": 0.5,
    "unrecordedunconditionalpurchaseobligationterm": "P18M",
    "royaltyrate": 0.01,
    "losscontingencydamagessoughtvalue": 6700000,
    "proffereddocuments": 1182,
    "losscontingencydamagesawardedvalue": 28382,
    "royaltiesannualnetsalespercentage": 0.06,
    "salarieswagesandofficerscompensation": 711000,
    "adjustmentstoadditionalpaidincapitalstocksplit": 105,
    "classofwarrantorrightoutstanding": 1843,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 98.89,
    "expirydate": "2030-09-22",
    "commonstockcapitalsharesreservedforfutureissuance": 150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 116511,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 6.34,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 2342,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 18324,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 44.56,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 121000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 23812,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 231000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P2Y",
    "researchanddevelopmentarrangementcontracttoperformforotherscostsincurredgross": 5118000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2602000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 35164000,
    "equitymethodinvestmentownershippercentage": 0.5,
    "preferredstockdividendratepercentage": 0.05,
    "incometaxcreditsandadjustments": 19417000,
    "lineofcreditfacilityannualprincipalpayment": 4100000,
    "currentfederalstateandlocaltaxexpensebenefit": 35164000,
    "taxableinvestmentsecuritiesaverageyield": 0.8,
    "milestonepayments": 103000000,
    "noticeperiodforterminating": "P90D",
    "researchservicefees": 250000,
    "descriptionofagreementrenderingofresearchservices": "In consideration for the research services, the Company agreedto pay research service fees of $1,286,000 in four equal quarterly installments ($321,500 per calendar quarter), as well as reasonablepass-through expenses.",
    "paymentsforfees": 343467,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "VIRPAX PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1708331,
    "entityfilenumber": "001-40064",
    "entitytaxidentificationnumber": "82-1510982",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "1055 Westlakes Drive",
    "entityaddressaddressline2": "Suite 300",
    "entityaddresscityortown": "Berwyn",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19312,
    "cityareacode": "(610)",
    "localphonenumber": "727-4597",
    "security12btitle": "Common Stock, par value $0.00001 per share",
    "tradingsymbol": "VRPX",
    "securityexchangename": "NASDAQ",
    "auditorname": "EisnerAmper LLP",
    "auditorfirmid": 274,
    "auditorlocation": "Philadelphia, Pennsylvania"
  },
  {
    "date": "2022-12-30",
    "symbol": "VRPX",
    "period": "FY",
    "cash": 18995284,
    "prepaidexpenseandotherassetscurrent": 678365,
    "assetscurrent": 19673649,
    "assets": 19673649,
    "accountspayableandaccruedliabilitiescurrent": 1094590,
    "litigationreservecurrent": 2000000,
    "liabilitiescurrent": 3094590,
    "liabilities": 3094590,
    "commonstockvalue": 117,
    "additionalpaidincapital": 60933569,
    "retainedearningsaccumulateddeficit": -44354627,
    "stockholdersequity": -44354627,
    "liabilitiesandstockholdersequity": 19673649,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 11714284,
    "commonstocksharesoutstanding": 11714284,
    "generalandadministrativeexpense": 11082463,
    "researchanddevelopmentexpense": 270000,
    "operatingexpenses": 21845133,
    "operatingincomeloss": -21845133,
    "otherincome": 194413,
    "othernonoperatingincomeexpense": 194413,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -21650720,
    "netincomeloss": -21650720,
    "earningspersharebasic": -1.85,
    "weightedaveragenumberofsharesoutstandingbasic": 11712186,
    "earningspersharediluted": -1.85,
    "weightedaveragenumberofdilutedsharesoutstanding": 11712186,
    "sharesoutstanding": 11714284,
    "stockissuedduringperiodvaluesharebasedcompensationgross": 745034,
    "stockissuedduringperiodsharesrestrictedstockawardforfeited": 601,
    "sharebasedcompensation": 745034,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2052079,
    "increasedecreaseinaccountspayableandaccruedliabilities": -993101,
    "increasedecreaseinothercurrentliabilities": 2000000,
    "netcashprovidedbyusedinoperatingactivities": -17846708,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -17846708,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 18995284,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 237,
    "prepaidinsurance": 156754,
    "prepaidresearchanddevelopment": 496270,
    "otherprepaidexpensecurrent": 25341,
    "prepaidexpenseandotherassetsnoncurrent": 678365,
    "accruedpayroll": 654765,
    "accruedresearchanddevelopmentexpenses": 254904,
    "legalfees": 147277,
    "otheraccountspayableandaccruedliabilities": 37644,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 1094590,
    "othergeneralandadministrativeexpense": 598655,
    "otherresearchanddevelopmentexpense": 146379,
    "allocatedsharebasedcompensationexpense": 745034,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0196,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7712000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1172281,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 15591,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 620734,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 518805,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": 8.11,
    "deferredtaxassetsoperatinglosscarryforwards": 8206000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 2868000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 922000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 743000,
    "deferredtaxassetsinprocessresearchanddevelopment": 546000,
    "deferredtaxassetsother": 6000,
    "deferredtaxassetsgross": 13291000,
    "deferredtaxassetsvaluationallowance": 13291000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.079,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.31,
    "effectiveincometaxratereconciliationotheradjustments": 0.021,
    "netincomelossattributabletoparentdiluted": 21650720,
    "taxbenefit": 0.5,
    "potentialdamages": 35000000,
    "estimatedlitigationliability": 2000000,
    "warrantstopurchasecommonshares": 90000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 12.5,
    "warrantexercisepercentage": 1.25,
    "numberofcomplexandsubjectivevariables": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardfairvalueassumptionsriskfreeinterestrate": 0.006,
    "classofwarrantorrightoutstanding": 18436,
    "unvestedrestrictedstockawards": 237,
    "equityfairvalueadjustment": 2342,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 37520,
    "sharebasedgoodsandnonemployeeservicestransactiondescriptionofgoodsorservicesreceived": "The 2022 Plan provides that: ",
    "deferredtaxexpensefromstockoptionsexercised": 707514,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 519190,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 1.64,
    "incometaxexaminationdescription": "The Tax Cuts and Jobs Act modified the section174 rules and beginning in 2022, taxpayers may no longer currently deduct R&D expenditures but instead must amortize specified R&Dexpenditures ratably over five years (or 15 years for foreign expenditures). Gross capitalized R&D Costs for the year ended December31, 2022 amounted to approximately $10,559,000. ",
    "deferredtaxassetsnet": 6623000,
    "operatinglosscarryforwards": 28397000,
    "netoperatinglossdescription": "From the total of the Company’s federalNOL of $28,397,000, $326,000 expires in 2037, and the remaining NOL has an indefinite carryover period but its usage is limited to 80%of taxable income in any subsequent year. The Company’s state NOL’s of $28,397,000 expire from 2037 through 2042. Additionally,the Company has $546,000 of R&D credits which have a 20 year carryforward period, which will expire from 2038 to 2042.",
    "researchanddevelopmentexpenses1": 250000,
    "researchanddevelopmentexpenses": 990000,
    "entityregistrantname": "VIRPAXPHARMACEUTICALS, INC.",
    "tradingsymbol": "VRPX",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1708331,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40064",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "82-1510982",
    "entityaddressaddressline1": "1055 Westlakes Drive",
    "entityaddressaddressline2": "Suite 300",
    "entityaddresscityortown": "Berwyn",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19312,
    "cityareacode": "(610)",
    "localphonenumber": "727-4597",
    "security12btitle": "Common Stock, par value $0.00001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 274,
    "auditorname": "EisnerAmper LLP",
    "auditorlocation": "Philadelphia, Pennsylvania"
  },
  {
    "date": "2021-12-30",
    "symbol": "VRPX",
    "period": "FY",
    "cash": 36841992,
    "prepaidexpenseandotherassetscurrent": 2730444,
    "assetscurrent": 39572436,
    "assets": 39572436,
    "accountspayableandaccruedliabilitiescurrent": 2087691,
    "notespayable": 500000,
    "liabilitiescurrent": 2087691,
    "liabilities": 2087691,
    "commonstockvalue": 117,
    "additionalpaidincapital": 60188535,
    "retainedearningsaccumulateddeficit": -22703907,
    "stockholdersequity": -22703907,
    "liabilitiesandstockholdersequity": 39572436,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 11714885,
    "commonstocksharesoutstanding": 11714885,
    "generalandadministrativeexpense": 7186385,
    "researchanddevelopmentexpense": 4839115,
    "operatingexpenses": 12025500,
    "operatingincomeloss": -12025500,
    "interestexpense": 92822,
    "othernonoperatingincome": 62259,
    "othernonoperatingincomeexpense": -30563,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -12056063,
    "netincomeloss": -12056063,
    "earningspersharebasic": -1.81,
    "weightedaveragenumberofsharesoutstandingbasic": 6677271,
    "sharesoutstanding": 11714885,
    "stockissuedduringperiodvalueother": 15783207,
    "stockissuedduringperiodsharesother": 1800000,
    "commonstockissuedpursuanttosecondaryofferingnetofexpenses": 36999465,
    "commonstockissuedpursuanttosecondaryofferingnetofexpensesinshares": 6670000,
    "stockissuedduringperiodsharesstockoptionsexercised": 85669,
    "stockissuedduringperiodvaluesharebasedcompensationgross": 974234,
    "stockissuedduringperiodvaluerestrictedstockawardsgranted": -1,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": -15000,
    "stockissuedduringperiodsharesrestrictedstockawardforfeited": -937,
    "forgivenessofppploans": 61816,
    "sharebasedcompensation": 974234,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2712171,
    "increasedecreaseinaccountspayableandaccruedliabilities": -686776,
    "netcashprovidedbyusedinoperatingactivities": -14542592,
    "repaymentsofnotespayable": 503764,
    "proceedsfromrelatedpartydebt": 100000,
    "repaymentsofrelatedpartydebt": 1100000,
    "paymentsofstockissuancecosts": 3020535,
    "proceedsfromsecondaryofferingofcommonstock": 40020000,
    "paymentsoffinancingcosts": 2165913,
    "proceedsfromissuanceinitialpublicoffering": 18000000,
    "netcashprovidedbyusedinfinancingactivities": 51329788,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 36787196,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 36841992,
    "interestpaidnet": 362822,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 18436,
    "prepaidinsurance": 152801,
    "legalretainer": 103050,
    "consultingfees": 8453,
    "otherresearchanddevelopmentexpense": 2466140,
    "accruedpayroll": 627281,
    "accruedresearchanddevelopmentexpenses": 930561,
    "accruedliabilitieslegalexpenses": 510008,
    "accruedaccountingconsultingfees": 4166,
    "accruedtaxexpenses": 8000,
    "otheraccountspayableandaccruedliabilities": 7675,
    "accountpayableandaccruedliabilitiescurrent": 2087691,
    "notespayablerelatedpartiescurrentandnoncurrent": 1100000,
    "relatedpartynotespayablenotesissuedbalance": 100000,
    "relatedpartynotespayablenotepayments": -100000,
    "totalrelatedpartynotespayabledebtforgiveness": -61816,
    "totalrelatedpartynotespayablenoteissued": 100000,
    "notespayablesnotepayments": 10284,
    "totalnotespayabledebtforgiveness": -61816,
    "totalnotespayablenoteissued": 100000,
    "totalnotespayablesnotepayments": -1603764,
    "lesscurrentportionofnotespayablesdebtforgiveness": -61816,
    "lesscurrentportionofnotespayablesnotesissued": 100000,
    "lesscurrentportionofnotespayablesnotepayments": -582174,
    "totalnotespayablenotepayments": -1021590,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.010400000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7898000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 669067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": 8.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 424769,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 9.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 5000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.62,
    "stocksissuedduringperiodsharesstockoptionsexercised": 87751,
    "weightedaverageexercisepriceexercisedinshares": 9.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 275717,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.62,
    "deferredtaxassetsoperatinglosscarryforwards": 5771000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 805000,
    "deferredtaxassetsinprocessresearchanddevelopment": 86000,
    "deferredtaxassetsother": 6000,
    "deferredtaxassetsgross": 6668000,
    "deferredtaxassetsvaluationallowance": 6668000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.218,
    "effectiveincometaxratereconciliationotheradjustments": 0.008,
    "netincomelossattributabletoparentdiluted": 12056063,
    "investmentcompanydistributableearnings": 22703907,
    "sharesissued": 40221,
    "taxbenefit": 0.5,
    "debtinstrumentfaceamount": 500000,
    "debtinstrumentincreaseaccruedinterest": 149977,
    "debtinstrumentfee": "two",
    "repaymentsofdebt": 10284,
    "interestexpensedebt": 92822,
    "excessstocksharesissued": 45448,
    "stockoptionexerciseprice": 87751,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 90000,
    "commonstockconvertibleconversionpriceincrease": 12.5,
    "initialpublicofferingpercentage": 1.25,
    "fairvalueofwarrantsissuedtounderwriters": 639000,
    "numberofcomplexandsubjectivevariables": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardfairvalueassumptionsriskfreeinterestrate": 0.006,
    "exerciseofwarrants": 76620,
    "warrantsexercised": 18436,
    "equitymethodinvestmentownershippercentage": 0.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 974234,
    "othergeneralandadministrativeexpense": 915423,
    "stockbasedcompensationwithinresearchanddevelopmentexpense": 58811,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.05,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 494570,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 1.9,
    "deferredtaxassetsnet": 3460000,
    "operatinglosscarryforwards": 19974000,
    "netoperatinglossdescription": "From the total of the Company’s federalNOL of $19,974,000, $326,000 expires in 2037, and the remaining NOL has an indefinite carryover period but its usage is limited to 80%of taxable income in any subsequent year. The Company’s state NOL’s of $19,974,000 expire from 2037 through 2041.",
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 19974000,
    "researchanddevelopmentexpenses": 870000,
    "researchanddevelopmentexpenses1": 250000,
    "entityregistrantname": "VIRPAXPHARMACEUTICALS, INC.",
    "tradingsymbol": "VRPX",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1708331,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40064",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "82-1510982",
    "entityaddressaddressline1": "1055 Westlakes Drive",
    "entityaddressaddressline2": "Suite 300",
    "entityaddresscityortown": "Berwyn",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19312,
    "cityareacode": "(610)",
    "localphonenumber": "727-4597",
    "security12btitle": "Common Stock, par value $0.00001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 274,
    "auditorname": "EisnerAmper LLP",
    "auditorlocation": "Philadelphia, Pennsylvania"
  }
]